Acute Myeloid Leukemia: An Ever-Changing Disease

Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Nix, Nancy M., Price, Allyson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Introduction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521118/
http://dx.doi.org/10.6004/jadpro.2019.10.8.12
_version_ 1783587913078931456
author Nix, Nancy M.
Price, Allyson
author_facet Nix, Nancy M.
Price, Allyson
author_sort Nix, Nancy M.
collection PubMed
description Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of these new approvals, this article provides an update for advanced practitioners on risk stratification, which is critical for guiding treatment selection.
format Online
Article
Text
id pubmed-7521118
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-75211182021-02-02 Acute Myeloid Leukemia: An Ever-Changing Disease Nix, Nancy M. Price, Allyson J Adv Pract Oncol Introduction Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of these new approvals, this article provides an update for advanced practitioners on risk stratification, which is critical for guiding treatment selection. Harborside Press LLC 2019 2019-11-01 /pmc/articles/PMC7521118/ http://dx.doi.org/10.6004/jadpro.2019.10.8.12 Text en © 2019 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Introduction
Nix, Nancy M.
Price, Allyson
Acute Myeloid Leukemia: An Ever-Changing Disease
title Acute Myeloid Leukemia: An Ever-Changing Disease
title_full Acute Myeloid Leukemia: An Ever-Changing Disease
title_fullStr Acute Myeloid Leukemia: An Ever-Changing Disease
title_full_unstemmed Acute Myeloid Leukemia: An Ever-Changing Disease
title_short Acute Myeloid Leukemia: An Ever-Changing Disease
title_sort acute myeloid leukemia: an ever-changing disease
topic Introduction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521118/
http://dx.doi.org/10.6004/jadpro.2019.10.8.12
work_keys_str_mv AT nixnancym acutemyeloidleukemiaaneverchangingdisease
AT priceallyson acutemyeloidleukemiaaneverchangingdisease

Ejemplares similares